{"transactions":[{"id":691955,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25041,"kind":"person","name":"Li Yishan","position":1,"cik":"0001772233","reported_name":"Li Yishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series B Preferred Stock","published_at":"2026-08-10T22:23:18.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":124779,"ownership":{"direct":false,"nature":"By RongShan, LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is manager of RongShan, LLC and may be deemed to have voting and dispositive power over the securities held by RongShan.LLC. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an\nadmission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":124779},"source":{"system":"sec-edgar","filing":"0001772233-26-000005","document":"form4-08102026_100812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177223326000005/form4-08102026_100812.xml","form_type":"4"}},{"id":691954,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25041,"kind":"person","name":"Li Yishan","position":1,"cik":"0001772233","reported_name":"Li Yishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series B Preferred Stock","published_at":"2026-08-10T22:23:18.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":113435,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":113435},"source":{"system":"sec-edgar","filing":"0001772233-26-000005","document":"form4-08102026_100812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177223326000005/form4-08102026_100812.xml","form_type":"4"}},{"id":691953,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25041,"kind":"person","name":"Li Yishan","position":1,"cik":"0001772233","reported_name":"Li Yishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Series Angel Preferred Stock","published_at":"2026-08-10T22:23:18.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":false,"shares":1600682,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1600682},"source":{"system":"sec-edgar","filing":"0001772233-26-000005","document":"form4-08102026_100812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177223326000005/form4-08102026_100812.xml","form_type":"4"}},{"id":691952,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25041,"kind":"person","name":"Li Yishan","position":1,"cik":"0001772233","reported_name":"Li Yishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-10T22:23:18.000Z","date":"2026-08-06","kind":"grant","planned":false,"acquired":true,"shares":112701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the shares subject to the option shall vest on August 6, 2027, and the balance of the shares shall vest in equal monthly installments over the following 36 months."}],"balance_after":112701,"derivative":{"exercise_price":16,"expiration_date":"2036-08-05","underlying":"Common Stock","underlying_shares":112701},"source":{"system":"sec-edgar","filing":"0001772233-26-000005","document":"form4-08102026_100812.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177223326000005/form4-08102026_100812.xml","form_type":"4"}},{"id":691951,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25041,"kind":"person","name":"Li Yishan","position":1,"cik":"0001772233","reported_name":"Li Yishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-08-10T22:23:18.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":124779,"ownership":{"direct":false,"nature":"By RongShan, LLC"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person is manager of RongShan, LLC and may be deemed to have voting and dispositive power over the securities held by RongShan.LLC. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an\nadmission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":124779,"source":{"system":"sec-edgar","filing":"0001772233-26-000005","document":"form4-08102026_100812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177223326000005/form4-08102026_100812.xml","form_type":"4"}},{"id":691950,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25041,"kind":"person","name":"Li Yishan","position":1,"cik":"0001772233","reported_name":"Li Yishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-08-10T22:23:18.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":113435,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":1714117,"source":{"system":"sec-edgar","filing":"0001772233-26-000005","document":"form4-08102026_100812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177223326000005/form4-08102026_100812.xml","form_type":"4"}},{"id":691949,"issuer":{"id":5423,"kind":"organization","name":"BlossomHill Therapeutics, Inc."},"owners":[{"id":25041,"kind":"person","name":"Li Yishan","position":1,"cik":"0001772233","reported_name":"Li Yishan","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2026-08-10T22:23:18.000Z","date":"2026-08-10","kind":"exercise","planned":false,"acquired":true,"shares":1600682,"ownership":{"direct":false,"nature":"By The Li and Cui Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Angel Preferred Stock and Series B Preferred Stock (together, the \"Preferred Stock\") automatically converted into 1 share of Common Stock upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of The Li and Cui Family Trust (the \"Trust\") and have voting and dispositive power over the securities held by the Trust."}],"balance_after":1600682,"source":{"system":"sec-edgar","filing":"0001772233-26-000005","document":"form4-08102026_100812.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1839970/000177223326000005/form4-08102026_100812.xml","form_type":"4"}}]}